BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin X, Shen C, Yin Y, Chen H, Chen H, Yin Y, Han L, Chen J, Tang S, Chen Z, Zhang B. Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme. Asia-Pac J Clin Oncol 2018;14:e37-44. [DOI: 10.1111/ajco.12760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Stueger A, Winder T, Tinguely M, Petrausch U, Helbling D. Metastatic Mixed Adenoneuroendocrine Carcinoma of the Colon with Response to Immunotherapy with Pembrolizumab: A Case Report. J Immunother. 2019;42:274-277. [PMID: 31219972 DOI: 10.1097/cji.0000000000000279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
2 Frizziero M, Chakrabarty B, Nagy B, Lamarca A, Hubner RA, Valle JW, McNamara MG. Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis. J Clin Med. 2020;9. [PMID: 31963850 DOI: 10.3390/jcm9010273] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
3 Yang M, Zeng L, Hou SZ, Ke NW, Tian BL, Liu XB, Xiang B, Zhang Y. Clinical Features and Long-Term Survival of Metastatic Hepatic Neuroendocrine Neoplasms Secondary to Gastroenteropancreatic Site: An Analysis by Applying the Grading Classification. J Oncol 2020;2020:6572398. [PMID: 33014053 DOI: 10.1155/2020/6572398] [Reference Citation Analysis]